Webinar: AA in skin of color populations

Inclusive approaches: Addressing alopecia areata in skin of color populations

Watch the full session and then complete the knowledge assessment to test your understanding.

Would you like to self-assess your knowledge before watching? Click here to access the quiz.

Important note for logged-out users: Please complete the full session without exiting your browser. If you exit before finishing, you’ll need to restart from the beginning. We recommend logging in to avoid interruptions and preserve your progress.

Chapters
00:07 Clinical manifestations
11:06 Severity tools in diverse populations
23:20 Managing alopecia areata
34:14 Cultural sensitivity
45:40 Q&A

To view this resource, please enable “Functional Cookies” using the cookie icon at the bottom left of your screen. Learn more about how we use cookies in our privacy policy.

How does alopecia areata present in skin of color, and what makes its clinical features more nuanced? This webinar, chaired by Antonella Tosti, explores nuanced presentations, validated severity assessment tools, and evidence-based management strategies tailored to diverse populations.

Watch now to:

• Recognize distinctive clinical features of alopecia areata in patients with skin of color
• Apply validated tools for assessing disease severity
• Evaluate current treatment options for severe alopecia areata in patients with skin of color, focusing on efficacy and safety
• Integrate holistic, culturally sensitive approaches into patient care

Meet the experts

Antonella Tosti, MD

Antonella Tosti is Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery at the University of Miami, Florida, USA. Her main interests include dermatology, nail disorders, pathology, surgical approaches, and AA.

Disclosures: AbbVie, Almirall, Amgen LLC, Bristol Myers Squibb, DS Laboratories, Eli Lilly, L’Oréal/Vichy USA, Myovant, Ortho Dermatologics, Pfizer, Sun Pharmaceuticals, Thirty Madison, Veradermics, and WellBeauty Company LLC.

Arash Mostaghimi, MD, MPA, MPH

Arash Mostaghimi is Vice Chair of Clinical Trials and Innovation, Associate Professor of Dermatology, Director of the Dermatology Inpatient Service, and Co-Director of the Complex Medical Dermatology Fellowship at Brigham and Women’s Hospital, Boston, USA. His research focuses on understanding variations in dermatologic care and improving care delivery to optimize resource utilization, encourage patient autonomy, and reduce disparities.

Disclosures: Consultant or has led clinical trials for AbbVie, Aslan Pharmaceuticals, Boehringer Ingelheim, Dermatheory, Digital Diagnostics, Eli Lilly, Equillium, Hims & Hers, Legacy Healthcare, Pelage, Pfizer, and Sun Pharmaceuticals.

Kristen Lo Sicco, MD, FAAD

Kristen Lo Sicco is a full-time faculty member in The Ronald O Perelman Department of Dermatology at NYU Langone Health, New York, USA. She is an Associate Professor of Dermatology and the Director of the historic NYU Skin and Cancer Unit. Her clinical and research interests include diseases of the hair, scalp, and nails as well as complex medical dermatology.

Disclosures: Former investigator for Pfizer and Regen Lab. Consultant for Aquis, Eli Lilly, Pfizer, Priovant, Ro, and Veradermics.

Loren Krueger, MD

Loren Krueger is Assistant Professor of Dermatology at the Emory University School of Medicine, Atlanta, Georgia, USA. She has a special interest in pigmentary disorders and hair disorders.

Disclosures: Nothing to declare.